browse Browse

pac.dog pac.dog / Lobbying

1st Quarter - Report · 2026

Filing UUID
97697ad8-cd57-4da4-a7e0-94a8555ee7b9
Type
Q1 — 1st Quarter - Report
Period
first_quarter
Year
2026
Posted
2026-04-20 17:44:49
Income (reported)
—
Expenses (reported)
$460,000
Expenses method
A
Filing document
Open on lda.senate.gov

Registrant (lobbying firm)

EISAI INC.

Pharmaceutical development, manufacturing and distribution -- Health Care

Contact
TRICIA BROOKS
Phone
+1 202-934-3735
Address
zip:07110, city:Nutley, state:NJ, street:200 Metro Boulevard

Client

EISAI INC.

State
NJ
Country
US
Government-entity client
false
Effective date
2022-01-28

Issues lobbied + lobbyists

MMM — Medicare/Medicaid

General issues related to Medicare and Medicaid, including: Part D Medicare Program; CMMI Drug Pricing Demonstration Programs; drug pricing; Alzheimers Screening and Prevention Act (ASAP) (HR 6130, S 3267); Concentrating on High-value Alzheimers Needs to Get to an End Act (CHANGE) (HR 4752. S 2379).

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

TAX — Taxation/Internal Revenue Code

Issues related to tax reform; H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

TRD — Trade (domestic/foreign)

Issues related to supply chain manufacturing and tariffs; Section 232 tariff investigation on branded pharmaceuticals.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

CPT — Copyright/Patent/Trademark

Issues related to pharmaceutical Intellectual Property (IP).

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

MAN — Manufacturing

Issues related to pharmaceutical manufacturing.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

HCR — Health Issues

Regulatory and legislative health care issues, including: Alzheimer's drug development; drug pricing; pharmaceutical scheduling; TRICARE coverage issues in FY2027 National Defense Authorization Act; PBM reform; S.891, Bipartisan Health Care Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Executive Order.

Lobbyists:

Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE

pac.dog is a free, independent, non-partisan research tool. Every candidate, committee, bill, vote, member, and nonprofit on this site is mirrored from primary U.S. government sources (FEC, congress.gov, govinfo.gov, IRS) and each state's Secretary of State / election commission — no third-party data vendors, no paywall, no editorial intermediation. Citations to the originating source are on every detail page.